Clinical Trial Details

Overview

Research Study Summary

Opportunity to participate: New Psoriasis Study Being Conducted

Purpose

Skin Conditions: Must have moderate to severe plaque-type psoriasis.

Name of Medication Being Tested: Etanercept (Enbrel ®)

Criteria Needed to be Entered into Study:

  • Children 4 to 17 years of age
  • Must have psoriasis for minimum of 6 months
  • Minimum 10% of total body surface area of psoriasis
  • Must have either one of the following medication history:
    • Have had or currently being treated with medication such as PUVA, UVB, UVA, Methotrexate, Cyclosporine, Retinoids
    • Poorly controlled with certain types of topical psoriasis therapy

Reasons Why You May Not Qualify: Have used Enbrel in the past

Study Specifics:

  • 52 to 57 week study with 16 visits
  • Study enrollment begins August 2004

If you are interested in receiving more information about this research study or are interested in being involved in the research,

To Learn more

CW ID: 71849
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
4 to 17 Years
Overall Status
Recruiting
Duration
57 Weeks
Facility Type
N/A

Contact

Clinical Partners, LLC
1524 Atwood Ave, Suite #330
Johnston, RI 02919
Phone: 401-454-3800

View Map

Research Center Information:

Clinical Partners, LLC

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.